Harrow Inc (HROW) Stock: What Does the Chart Say Monday?

Harrow Inc (HROW) stock is up 13.44% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Harrow Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on HROW!

See Full HROW Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With HROW Stock Today?

Harrow Inc (HROW) stock is up 3.48% while the S&P 500 is down -0.18% as of 1:55 PM on Monday, Mar 25. HROW has risen $0.40 from the previous closing price of $11.50 on volume of 594,364 shares. Over the past year the S&P 500 is up 31.36% while HROW is down -44.55%. HROW lost -$0.75 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Harrow Inc click here.

More About Harrow Inc

Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits. Click Here to get the full Stock Report for Harrow Inc stock.